Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?
Arbutus Biopharma Ownership Summary
Arbutus Biopharma is owned by 54.89% institutional investors, 22.23% insiders, and 22.88% retail investors. Morgan stanley is the largest institutional shareholder, holding 11.93% of ABUS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.
ABUS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Arbutus Biopharma | 54.89% | 22.23% | 22.88% |
| Sector | Healthcare Stocks | 57.38% | 9.40% | 33.23% |
| Industry | Biotech Stocks | 68.97% | 8.91% | 22.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Morgan stanley | 20.96M | 11.93% | $64.77M |
| Whitefort capital management, lp | 13.24M | 7.01% | $43.30M |
| Blackrock funding, inc. /de | 12.94M | 6.85% | $42.31M |
| Blackrock | 11.55M | 6.58% | $35.70M |
| Vanguard group | 8.98M | 4.75% | $29.37M |
| Two seas capital lp | 8.74M | 4.62% | $28.58M |
| State street | 5.03M | 2.66% | $16.44M |
| Geode capital management | 3.48M | 1.84% | $11.39M |
| Blackbarn capital partners lp | 2.34M | 1.24% | $7.66M |
| Rubric capital management lp | 1.68M | 0.89% | $5.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Whitefort capital management, lp | 13.24M | 20.72% | $43.30M |
| Corbin capital partners | 682.49K | 3.64% | $2.23M |
| Two seas capital lp | 8.74M | 2.47% | $28.58M |
| Fourworld capital management | 1.23M | 2.08% | $4.01M |
| Adar1 capital management | 1.55M | 1.02% | $5.08M |
| Blackbarn capital partners lp | 2.34M | 0.42% | $7.66M |
| Quinn opportunity partners | 404.88K | 0.09% | $1.32M |
| Rubric capital management lp | 1.68M | 0.07% | $5.50M |
| Exome asset management | 28.30K | 0.07% | $92.54K |
| Saba capital management | 887.99K | 0.07% | $2.90M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 20.96M | 0.01% | 12.13M |
| Blackrock | 11.55M | 0.00% | 1.15M |
| Jpmorgan chase | 896.26K | 0.00% | 806.67K |
| Blackrock funding, inc. /de | 12.94M | 0.00% | 718.70K |
| State street | 5.03M | 0.00% | 619.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fourworld capital management | 1.23M | 2.08% | -1.75M |
| Adage capital partners gp | 1.65M | 0.01% | -1.25M |
| Adar1 capital management | 1.55M | 1.02% | -534.52K |
| Boothbay fund management | 162.28K | 0.01% | -450.00K |
| Corbin capital partners | 682.49K | 3.64% | -170.82K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Susquehanna fundamental investments | 202.54K | 0.01% | 202.54K | $662.31K |
| Franklin resources | 92.16K | 0.00% | 92.16K | $301.36K |
| Caption management | 69.60K | 0.00% | 69.60K | $227.59K |
| Balyasny asset management | 41.69K | 0.00% | 41.69K | $136.33K |
| Ballentine partners | 31.12K | 0.00% | 31.12K | $101.77K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -3.00 |
| Nelson, van denburg & campbell wealth management group | -24.00 |
| Central trust | -100.00 |
| Opal wealth advisors | -100.00 |
| Capital performance advisors llp | -545.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 161 | 5.23% | 103,747,487 | 2.96% | 54 | 1.93% | 73 | -5.19% | 44 | 41.94% |
| Sep 30, 2024 | 153 | 12.50% | 100,767,700 | 4.58% | 53 | 2.03% | 77 | 8.45% | 31 | 3.33% |
| Jun 30, 2024 | 135 | 5.47% | 96,359,003 | 16.04% | 54 | 2.19% | 71 | 26.79% | 30 | -6.25% |
| Mar 31, 2024 | 128 | 4.92% | 83,042,471 | 5.67% | 50 | 2.27% | 56 | 7.69% | 32 | 14.29% |
| Dec 31, 2023 | 122 | 15.09% | 78,586,633 | 11.02% | 46 | 2.58% | 52 | 33.33% | 28 | 16.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.87M | 2.57% | - |
| Morgan Stanley Insight | 4.24M | 2.24% | 399.58K |
| iShares Russell 2000 ETF | 3.85M | 2.03% | -75.28K |
| Morgan Stanley Insight A | 3.85M | 2.03% | -392.53K |
| MS INVF Global Insight Z | 2.50M | 1.32% | - |
| Morgan Stanley Inception | 2.28M | 1.21% | 81.82K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.22M | 1.17% | 1.07K |
| Morgan Stanley Inst Inception I | 2.20M | 1.16% | -221.83K |
| EQ/Morgan Stanley Small Cap Growth K | 1.78M | 0.94% | - |
| SPDR® S&P Biotech ETF | 1.57M | 0.83% | 11.88K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 04, 2025 | HASTINGS DAVID C | Chief Financial Officer | Sell | $72.83K |
| Feb 04, 2025 | Sims Karen | Chief Medical Officer | Sell | $63.52K |
| Feb 04, 2025 | McElhaugh Michael J. | Interim President & CEO | Sell | $78.10K |
| Feb 04, 2025 | Naftzger J. Christopher | General Counsel and CCO | Sell | $37.21K |
| Aug 14, 2024 | MANCHESTER KEITH S | - | Sell | $32.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 4 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 4 |
| 2023 Q3 | - | - |
ABUS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools